1. Home
  2. REVB vs BYAH Comparison

REVB vs BYAH Comparison

Compare REVB & BYAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$0.48

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Logo Park Ha Biological Technology Co. Ltd. Ordinary Shares

BYAH

Park Ha Biological Technology Co. Ltd. Ordinary Shares

BUY

Current Price

$2.29

Market Cap

1.9M

ML Signal

BUY

Company Overview

Basic Information
Metric
REVB
BYAH
Founded
2020
2016
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
1.9M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
REVB
BYAH
Price
$0.48
$2.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.4K
★ 93.5K
Earning Date
11-05-2026
07-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 72.68
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.05
52 Week High
$2.32
$6.64

Technical Indicators

Market Signals
Indicator
REVB
BYAH
Relative Strength Index (RSI) 22.76 44.02
Support Level $0.47 $1.97
Resistance Level $1.21 $3.26
Average True Range (ATR) 0.06 0.28
MACD -0.02 -0.03
Stochastic Oscillator 2.06 26.37

Price Performance

Historical Comparison
REVB
BYAH

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

About BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.

Share on Social Networks: